Narsimha R. Candula

Narsimha Candula practices at HCA Florida Memorial Hospital in Jacksonville, Florida, part of HCA Healthcare.

Narsimha Candula's NPI, 1932545175, was assigned on May 15, 2013. Narsimha Candula graduated from Gandhi Medical College in 2004. Narsimha Candula holds Florida license ME115698.

Narsimha Candula's primary practice is HCA Florida Memorial Hospital, at 3625 University Blvd S, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 702-6111.

Narsimha Candula's primary practice is HCA Florida Memorial Hospital in Jacksonville, Florida, part of HCA Healthcare. Narsimha Candula is also affiliated with HCA Florida Putnam Hospital. The medical group on file is TeamHealth. Dmand AI also links Narsimha Candula to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Narsimha Candula practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Narsimha Candula's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Narsimha Candula is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Narsimha Candula's licenses on file in 3 states: Florida, Iowa and North Carolina.

Dmand AI lists acute diabetes, acute respiratory failure, cardiac arrhythmia, cellulitis, circulation problems, congestive heart failure, dementia and electrolyte disorders among the conditions Narsimha Candula treats.

CMS data shows 837 Medicare services from Narsimha Candula across 5 procedure codes in 2024, for 349 Medicare patients. Medicare paid $57,852 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 349 Medicare patients who saw Narsimha Candula in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Narsimha Candula's median patient age at 63, with 49% women.

In 2024, Narsimha Candula wrote 581 Medicare Part D claims for 235 patients. 87% of them were for generic drugs. CMS names the drug for 292 of them, across 15 drugs with 11 or more claims each, at $18,066 in total drug cost. In 2023, CMS named 217 claims across 11 drugs.

Narsimha Candula accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Narsimha Candula, published from 2020 to 2023. 2022 was the busiest year, with 6. Narsimha Candula has published most often in Cureus. Narsimha Candula's most frequent co-authors are Swetha Chenna, MD, Meet Atul Kadakia, MD and Ramesh Adhikari, MD.

CMS Open Payments shows 12 general payments to Narsimha Candula from 5 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $85.

Narsimha Candula graduated from Gandhi Medical College in 2004.

Narsimha Candula is in network with 5 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.